Table 4.
Subgroup analyses: depression treatments.
| Subgroup analysisa | Effects | Heterogeneity | Subgroup analysis | ||||||||
|
|
Nb | g | 95% CI | I2 | P value | I2 95% CI | Q value | P value (Q) | |||
| Recruitment pathwayc | |||||||||||
|
|
Clinical and community+clinical | 8 | 1.05 | 0.95-1.14 | 78 | <.001 | 56-89 | 7.253 | .007 | ||
|
|
Community | 5 | 1.38 | 1.16-1.59 | 96 | <.001 | 94-98 | 7.253 | .007 | ||
| Specific treatment | |||||||||||
|
|
Mixed treatment | 7 | 1.10 | 0.98-1.22 | 93 | <.001 | 87-96 | 0.736 | .39 | ||
|
|
Disorder-specific treatment | 6 | 1.27 | 0.91-1.62 | 97 | <.001 | 95-98 | 0.736 | .39 | ||
| Diagnosis conductedd | |||||||||||
|
|
Interview | 7 | 1.127 | 0.89-1.35 | 97 | <.001 | 95-98 | 0.946 | .33 | ||
|
|
Questionnaire | 5 | 1.25 | 1.16-1.34 | 81 | <.001 | 57-92 | 0.946 | .33 | ||
| Clinical cutoff/minimal symptom severity | |||||||||||
|
|
Yes | 4 | 1.27 | 1.08-1.45 | 84 | <.001 | 60-94 | 0.897 | .34 | ||
|
|
No | 7 | 1.17 | 0.98-1.35 | 96 | <.001 | 94-97 | 0.897 | .34 | ||
| Treatment duration | |||||||||||
|
|
<9 weeks | 5 | 1.17 | 1.01-1.32 | 95 | <.001 | 92-97 | 7.485 | .02 | ||
|
|
9-13 weeks | 4 | 1.00 | 0.95-1.05 | 0 | .85 | 0-85 | 7.485 | .02 | ||
|
|
>13 weeks | 4 | 1.37 | 1.00-1.74 | 97 | <.001 | 94-98 | 7.485 | .02 | ||
| Guide cognitive behavioral therapy training (profession)e | |||||||||||
|
|
Nonprofessional | 4 | 0.92 | 0.79-1.05 | 22 | .28 | 0-88 | 14.151 | <.001 | ||
|
|
Other | 9 | 1.27 | 1.14-1.40 | 96 | <.001 | 94-97 | 14.151 | <.001 | ||
| Guide supervision provided | |||||||||||
|
|
No | 4 | 0.91 | 0.75-1.08 | 39 | .18 | 0-79 | 10.339 | <.001 | ||
|
|
Yes | 9 | 1.27 | 1.13-1.41 | 96 | <.001 | 94-97 | 10.339 | <.001 | ||
| Guide training provided | |||||||||||
|
|
No | 6 | 0.98 | 0.94-1.02 | 7 | .37 | 0-76 | 21.368 | <.001 | ||
|
|
Yes | 7 | 1.35 | 1.20-1.51 | 95 | <.001 | 91-97 | 21.368 | <.001 | ||
| Intervention manual provided | |||||||||||
|
|
No | 9 | 1.039 | 0.95-1.137 | 75 | <.001 | 51-87 | 10.715 | <.001 | ||
|
|
Yes | 4 | 1.467 | 1.23-1.71 | 97 | <.001 | 95-98 | 10.715 | <.001 | ||
| Risk of bias—researcher allegiance | |||||||||||
|
|
High | 7 | 1.252 | 1.08-1.42 | 97 | <.001 | 95-98 | 1.347 | .25 | ||
|
|
Low | 5 | 1.119 | 0.99-1.29 | 70 | .01 | 23-88 | 1.347 | .25 | ||
| Risk of bias—confounding (treatment inclusion) | |||||||||||
|
|
High | 7 | 1.215 | 1.06-1.43 | 96 | <.001 | 94-98 | 0.985 | .32 | ||
|
|
Low | 5 | 1.105 | 0.98-1.23 | 82 | <.001 | 58-92 | 0.985 | .32 | ||
aTest against “Guidance format: face-to-face vs written guidance,” “Guidance modality: Message, Email, Telephone, F2F,” and “Guide profession” excluded, as there were too few studies included in analysis.
bNumber of studies.
cOnly two studies included via the clinical pathway only. We combined the categories “Both, community and clinical” and “clinical” for this analysis.
dExcluding one study [54], as this is the only study using clinical judgment without specifying the use of an interview or questionnaire.
eWe grouped all studies involving guides not specifically trained in delivering cognitive behavioral therapy in the category “non-professional” and studies involving psychiatrists, psychologists, or psychotherapists in their guidance in the category “other.”